AR093124A1 - COMPOSITIONS FOR THE TREATMENT OF SURFACES AND PROCESS FOR THE PRODUCTION OF A PARTICLE - Google Patents

COMPOSITIONS FOR THE TREATMENT OF SURFACES AND PROCESS FOR THE PRODUCTION OF A PARTICLE

Info

Publication number
AR093124A1
AR093124A1 ARP130103864A ARP130103864A AR093124A1 AR 093124 A1 AR093124 A1 AR 093124A1 AR P130103864 A ARP130103864 A AR P130103864A AR P130103864 A ARP130103864 A AR P130103864A AR 093124 A1 AR093124 A1 AR 093124A1
Authority
AR
Argentina
Prior art keywords
agents
particle
anion
benefit agent
fragrances
Prior art date
Application number
ARP130103864A
Other languages
Spanish (es)
Inventor
Qian Haitao
Clarkson Jones Christopher
Pan Xiaoyun
Zhang Yuanyuan
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of AR093124A1 publication Critical patent/AR093124A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/612—By organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

Reivindicación 1: Una partícula de administración de agente de beneficio caracterizada porque comprende una gente de beneficio, y presenta, en la superficie externa de la partícula, uno o más auxiliares de administración que incluyen una sal de quitosano, que comprende un componente de quitosano y un anión, donde el anión de dicha sal es un anión orgánico con un peso molecular mayor que 60, y donde el componente de quitosano comprende una estructura principal que comprende grupos amina. Reivindicación 8: Una partícula de administración de agente de beneficio de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizada porque el agente de beneficio se selecciona entre esencias y fragancias, pro-fragancias, arcillas, enzimas, agentes antiespuma, agentes de fluorescencia, agentes blanqueadores y sus precursores, tintes y/o pigmentos, agentes acondicionadores, lubricantes, agentes colorantes y de fotoprotección, antioxidantes, ceramidas, agentes de reducción, secuestrantes, aditivos para el cuidado de los colores, aceite insaturado, emolientes, humectantes, repelentes de insectos y/o feromonas, modificadores de caída, agentes antimicrobianos y de control de microbios y sus mezclas. Reivindicación 10: Una composición caracterizada porque comprende: a) una partícula de acuerdo con cualquiera de las reivindicaciones anteriores, y b) al menos un tensioactivo.Claim 1: A benefit agent administration particle characterized in that it comprises a benefit people, and has, on the outer surface of the particle, one or more administration auxiliaries that include a chitosan salt, which comprises a chitosan component and an anion, where the anion of said salt is an organic anion with a molecular weight greater than 60, and where the chitosan component comprises a main structure comprising amine groups. Claim 8: A benefit agent administration particle according to any of the preceding claims, characterized in that the benefit agent is selected from essences and fragrances, pro-fragrances, clays, enzymes, antifoam agents, fluorescence agents, bleaching agents and its precursors, dyes and / or pigments, conditioning agents, lubricants, coloring and photoprotection agents, antioxidants, ceramides, reducing agents, sequestrants, color care additives, unsaturated oil, emollients, humectants, insect repellents and / or pheromones, drop modifiers, antimicrobial and microbial control agents and mixtures thereof. Claim 10: A composition characterized in that it comprises: a) a particle according to any of the preceding claims, and b) at least one surfactant.

ARP130103864A 2012-10-25 2013-10-24 COMPOSITIONS FOR THE TREATMENT OF SURFACES AND PROCESS FOR THE PRODUCTION OF A PARTICLE AR093124A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012083501 2012-10-25

Publications (1)

Publication Number Publication Date
AR093124A1 true AR093124A1 (en) 2015-05-20

Family

ID=49485715

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103864A AR093124A1 (en) 2012-10-25 2013-10-24 COMPOSITIONS FOR THE TREATMENT OF SURFACES AND PROCESS FOR THE PRODUCTION OF A PARTICLE

Country Status (2)

Country Link
AR (1) AR093124A1 (en)
WO (1) WO2014064121A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016000912A1 (en) * 2014-06-30 2016-01-07 Unilever N.V. Benefit agent delivery particle and composition comprising the particle
BR112017023472B1 (en) * 2015-05-13 2021-10-13 Unilever Ip Holdings B.V BENEFICIAL AGENT SUPPLY PARTICLE, COMPOSITION AND PARTICLE PRODUCTION PROCESS
US10806233B2 (en) 2015-11-17 2020-10-20 Elc Management Llc Mascara composition and method
US10064806B2 (en) * 2015-11-17 2018-09-04 Elc Management Llc Mascara composition and method
BR112018007644B1 (en) 2015-11-17 2021-05-11 Unilever Ip Holdings B.V. microcapsule, process for manufacturing microcapsules and composition for hair care
WO2018077570A1 (en) * 2016-10-28 2018-05-03 Unilever N.V. A personal care composition comprising particles
US11471396B2 (en) * 2016-10-28 2022-10-18 Conopco, Inc. Personal care compositions comprising surface-modified particles and non-volatile funcationalised silicone
US11800917B2 (en) 2018-08-30 2023-10-31 L'oreal Hair-treatment compositions and methods of use
GB201815293D0 (en) 2018-09-20 2018-11-07 Givaudan Sa Improvements in or relating to organic compounds
US20220323922A1 (en) 2019-09-06 2022-10-13 Conopco, Inc., D/B/A Unilever Microcapsule and hair care composition
WO2021043627A1 (en) 2019-09-06 2021-03-11 Unilever Global Ip Limited Microcapsule and hair care composition
US20240156710A1 (en) * 2021-03-31 2024-05-16 Firmenich Sa Functionalized chitosan preparation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958581A (en) 1972-05-17 1976-05-25 L'oreal Cosmetic composition containing a cationic polymer and divalent metal salt for strengthening the hair
CA1018893A (en) 1972-12-11 1977-10-11 Roger C. Birkofer Mild thickened shampoo compositions with conditioning properties
US4009256A (en) 1973-11-19 1977-02-22 National Starch And Chemical Corporation Novel shampoo composition containing a water-soluble cationic polymer
DD137599A1 (en) 1978-07-19 1979-09-12 Detlef Kaufmann MEANS FOR THE THERMOREGULATED RELEASE OF PARFUEM IN THE WASHING PROCESS
US4539135A (en) 1983-06-01 1985-09-03 Colgate Palmolive Co. Perfume-containing carrier for laundry compositions
DD248508A1 (en) 1985-04-30 1987-08-12 Bitterfeld Chemie PERFUME DONORS
US5194639A (en) 1990-09-28 1993-03-16 The Procter & Gamble Company Preparation of polyhydroxy fatty acid amides in the presence of solvents
AU663851B2 (en) 1990-09-28 1995-10-26 Procter & Gamble Company, The Polyhydroxy fatty acid amide surfactants to enhance enzyme performance
GB9116871D0 (en) 1991-08-05 1991-09-18 Unilever Plc Hair care composition
US5543074A (en) 1994-02-18 1996-08-06 Chesebrough-Pond's Usa Co., Div. Of Conopco, Inc. Personal washing compositions
GB9507130D0 (en) 1995-04-06 1995-05-31 Unilever Plc Hair treatment composition
CA2249408A1 (en) 1996-03-22 1997-09-25 The Procter & Gamble Company Delivery system having release barrier loaded zeolite
JP4303789B2 (en) 1997-03-15 2009-07-29 ザ、プロクター、エンド、ギャンブル、カンパニー Delivery system
KR100566336B1 (en) * 1998-06-04 2006-03-31 가오가부시끼가이샤 Polymer emulsion and process for producing the same
DE19962348A1 (en) * 1999-12-23 2001-07-05 Henkel Kgaa Pigmented chitosan capsules
US20020094938A1 (en) 2000-11-08 2002-07-18 The Procter & Gamble Company Photo-labile pro-fragrance conjugates
ES2226567B1 (en) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela NANOPARTICULAS OF HIALURONIC ACID.
US8048453B1 (en) * 2005-01-04 2011-11-01 Gp Medical, Inc. Pharmaceutical composition of nanoparticles for protein drug delivery
US8226962B2 (en) * 2005-01-31 2012-07-24 The Hong Kong Polytechnic University Textiles with chitosan core-shell particles
GB0524659D0 (en) 2005-12-02 2006-01-11 Unilever Plc Improvements relating to fabric treatment compositions

Also Published As

Publication number Publication date
WO2014064121A2 (en) 2014-05-01
WO2014064121A3 (en) 2014-07-31

Similar Documents

Publication Publication Date Title
AR093124A1 (en) COMPOSITIONS FOR THE TREATMENT OF SURFACES AND PROCESS FOR THE PRODUCTION OF A PARTICLE
DOP2018000226A (en) NEW DERIVATIVES OF PIRAZOLOPIRIMIDINA
UY37831A (en) NEW DERIVATIVES OF QUINOLINA
CO2019004776A2 (en) New quinoline-3-carboxamide derivatives anthelmintics
DOP2019000206A (en) 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES
UY36665A (en) CICLOHEXAN DERIVATIVES REPLACED WITH AMIDAS
AR050946A1 (en) COMPOSITIONS FOR THE TREATMENT OF CLOTHING.
CO2019014484A2 (en) New azaquinoline derivatives
NI201100025A (en) METHODS OF ADMINISTRATION OF TOPICAL ANTIFUNGAL FORMULATIONS FOR THE TREATMENT OF FUNGAL INFECTIONS.
UY38428A (en) NEW ANTIFELMINE COMPOUNDS
UY36157A (en) COMPOSITIONS PESTICIDES AND PROCEDURES RELATED TO THE SAME
CR20130264A (en) PIRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP-PLA2
DOP2015000134A (en) SUSPENSION PESTICIDE WITH OIL BASE
BR112014014832A2 (en) formulation and method of controlling fungi
AR070025A1 (en) USE OF DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF COCLEAR TINNITUS AND PHARMACEUTICAL COMPOSITION
CL2020002891A1 (en) New quinoline derivatives
DOP2019000275A (en) NEW BICYCLIC PIRAZOLE DERIVATIVES
CL2021002263A1 (en) Antibacterial compounds (divisional application 202001147)
BR112012009188A2 (en) viscous acid abrasive cleaning compositions
AR077372A1 (en) COMPOSITIONS AND METHODS TO TREAT OTHAL OR NASAL OPHTHALM INFECTIONS
CL2018001590A1 (en) Pharmaceutical compositions comprising some phenylaminopyrimidine derivative.
CL2012000611A1 (en) 5- (3,4-Dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2,2-trifluoro-ethoxy) -nicotinamide compound, useful as an agent that increases hdl cholesterol; process for obtaining the compound; pharmaceutical composition; and its use for the treatment or prophylaxis of atherosclerosis, dyslipidemia, cardiovascular diseases, among others.
ECSP19044591A (en) AROMATIC AMIDES OF CARBOXYLIC ACID AS ANTAGONISTS OF THE B1 RECEPTOR OF BRADIQUININ
ECSP12011883A (en) PROCESS FOR TERTIARY OIL EXTRACTION USING MIXTURES OF TENSIOACTIVE AGENTS
NO20091517L (en) emulsion

Legal Events

Date Code Title Description
FB Suspension of granting procedure